Literature DB >> 25596308

mirTrios: an integrated pipeline for detection of de novo and rare inherited mutations from trios-based next-generation sequencing.

Jinchen Li1, Yi Jiang2, Tao Wang2, Huiqian Chen2, Qing Xie2, Qianzhi Shao2, Xia Ran2, Kun Xia3, Zhong Sheng Sun4, Jinyu Wu4.   

Abstract

OBJECTIVES: Recently, several studies documented that de novo mutations (DNMs) play important roles in the aetiology of sporadic diseases. Next-generation sequencing (NGS) enables variant calling at single-base resolution on a genome-wide scale. However, accurate identification of DNMs from NGS data still remains a major challenge. We developed mirTrios, a web server, to accurately detect DNMs and rare inherited mutations from NGS data in sporadic diseases.
METHODS: The expectation-maximisation (EM) model was adopted to accurately identify DNMs from variant call files of a trio generated by GATK (Genome Analysis Toolkit). The GATK results, which contain certain basic properties (such as PL, PRT and PART), are iteratively integrated into the EM model to strike a threshold for DNMs detection. Training sets of true and false positive DNMs in the EM model were built from whole genome sequencing data of 64 trios.
RESULTS: With our in-house whole exome sequencing datasets from 20 trios, mirTrios totally identified 27 DNMs in the coding region, 25 of which (92.6%) are validated as true positives. In addition, to facilitate the interpretation of diverse mutations, mirTrios can also be employed in the identification of rare inherited mutations. Embedded with abundant annotation of DNMs and rare inherited mutations, mirTrios also supports known diagnostic variants and causative gene identification, as well as the prioritisation of novel and promising candidate genes.
CONCLUSIONS: mirTrios provides an intuitive interface for the general geneticist and clinician, and can be widely used for detection of DNMs and rare inherited mutations, and annotation in sporadic diseases. mirTrios is freely available at http://centre.bioinformatics.zj.cn/mirTrios/. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.

Entities:  

Keywords:  de novo mutations; mirTrios; rare inherited mutations; sporadic diseases

Mesh:

Year:  2015        PMID: 25596308     DOI: 10.1136/jmedgenet-2014-102656

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  12 in total

1.  Identification of Novel Compound Mutations in PLA2G6-Associated Neurodegeneration Patient with Characteristic MRI Imaging.

Authors:  Sen Guo; Liu Yang; Huijie Liu; Wei Chen; Jinchen Li; Ping Yu; Zhong Sheng Sun; Xiang Chen; Jie Du; Tao Cai
Journal:  Mol Neurobiol       Date:  2016-07-09       Impact factor: 5.590

2.  Performance evaluation of pathogenicity-computation methods for missense variants.

Authors:  Jinchen Li; Tingting Zhao; Yi Zhang; Kun Zhang; Leisheng Shi; Yun Chen; Xingxing Wang; Zhongsheng Sun
Journal:  Nucleic Acids Res       Date:  2018-09-06       Impact factor: 16.971

3.  Targeted sequencing and functional analysis reveal brain-size-related genes and their networks in autism spectrum disorders.

Authors:  Jinchen Li; Lin Wang; Hui Guo; Leisheng Shi; Kun Zhang; Meina Tang; Shanshan Hu; Shanshan Dong; Yanling Liu; Tianyun Wang; Ping Yu; Xin He; Zhengmao Hu; Jinping Zhao; Chunyu Liu; Zhong Sheng Sun; Kun Xia
Journal:  Mol Psychiatry       Date:  2017-07-25       Impact factor: 15.992

4.  Trio-based exome sequencing arrests de novo mutations in early-onset high myopia.

Authors:  Zi-Bing Jin; Jinyu Wu; Xiu-Feng Huang; Chun-Yun Feng; Xue-Bi Cai; Jian-Yang Mao; Lue Xiang; Kun-Chao Wu; Xueshan Xiao; Bethany A Kloss; Zhongshan Li; Zhenwei Liu; Shenghai Huang; Meixiao Shen; Fei-Fei Cheng; Xue-Wen Cheng; Zhi-Li Zheng; Xuejiao Chen; Wenjuan Zhuang; Qingjiong Zhang; Terri L Young; Ting Xie; Fan Lu; Jia Qu
Journal:  Proc Natl Acad Sci U S A       Date:  2017-04-03       Impact factor: 11.205

5.  OncoBase: a platform for decoding regulatory somatic mutations in human cancers.

Authors:  Xianfeng Li; Leisheng Shi; Yan Wang; Jianing Zhong; Xiaolu Zhao; Huajing Teng; Xiaohui Shi; Haonan Yang; Shasha Ruan; MingKun Li; Zhong Sheng Sun; Qimin Zhan; Fengbiao Mao
Journal:  Nucleic Acids Res       Date:  2019-01-08       Impact factor: 16.971

6.  A novel deletion mutation in KMT2A identified in a child with ID/DD and blood eosinophilia.

Authors:  Haixia Zhang; Bingwu Xiang; Hui Chen; Xiang Chen; Tao Cai
Journal:  BMC Med Genet       Date:  2019-03-06       Impact factor: 2.103

7.  Identification of a Novel NLRP12 Nonsense Mutation (Trp408X) in the Extremely Rare Disease FCAS by Exome Sequencing.

Authors:  Xiaoru Xia; Caijun Dai; Xiaochun Zhu; Qiumei Liao; Xu Luo; Yangyang Fu; Liangxing Wang
Journal:  PLoS One       Date:  2016-06-17       Impact factor: 3.240

8.  VarCards: an integrated genetic and clinical database for coding variants in the human genome.

Authors:  Jinchen Li; Leisheng Shi; Kun Zhang; Yi Zhang; Shanshan Hu; Tingting Zhao; Huajing Teng; Xianfeng Li; Yi Jiang; Liying Ji; Zhongsheng Sun
Journal:  Nucleic Acids Res       Date:  2018-01-04       Impact factor: 16.971

9.  Three intellectual disability-associated de novo mutations in MECP2 identified by trio-WES analysis.

Authors:  Yi Gu; Bingwu Xiang; Lina Zhu; Xiuwei Ma; Xiang Chen; Tao Cai
Journal:  BMC Med Genet       Date:  2020-05-11       Impact factor: 2.103

10.  Whole-Exome Sequencing Reveals a Rare Missense Variant in SLC16A9 in a Pedigree with Early-Onset Gout.

Authors:  Xiu-Feng Huang; Li Sun; Chunwu Zhang; Zhenni Zhou; Hui Chen; Linhua Zhang; Matthew A Brown; Xiaoru Xia
Journal:  Biomed Res Int       Date:  2020-01-31       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.